Literature DB >> 14600613

Evaluation and treatment of metastases to the humerus.

Frank J Frassica1, Deborah A Frassica.   

Abstract

The humerus is the second most common long bone site of metastatic disease, and the proximal third and diaphysis are frequent sites. Purely lytic disease and cortical bone destruction increase the risk of fracture more than 50%. For most patients, external beam irradiation is effective as a means of pain control and halting bone destruction. Fractures of the head or surgical neck can be treated with standard endoprostheses, whereas extensive proximal bone destruction is treated with custom proximal humeral replacements. Impending and complete diaphyseal fractures can be treated effectively with either intramedullary nail fixation or plate fixation. Rigid fixation, which can be achieved with dual plate fixation, is optimal because patients can begin immediate unrestricted activities using the upper extremity. Methylmethacrylate is an effective adjuvant for filling defects and for augmenting the fixation of intramedullary nails and screws. Postoperative external beam irradiation is necessary to prevent progressive bone destruction and subsequent loss of fixation.

Entities:  

Mesh:

Year:  2003        PMID: 14600613     DOI: 10.1097/01.blo.0000093052.96273.a7

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  18 in total

1.  Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.

Authors:  Krista A Goulding; Adam Schwartz; Steven J Hattrup; R Lor Randall; Donald Lee; Damian M Rispoli; Daniel M Lerman; Christopher Beauchamp
Journal:  Clin Orthop Relat Res       Date:  2017-02-13       Impact factor: 4.176

2.  Does the second-generation intercalary humeral spacer improve on the first?

Authors:  Timothy A Damron; Taninnit Leerapun; Ronald R Hugate; Thomas C Shives; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2008-04-18       Impact factor: 4.176

3.  Mirels' score for upper limb metastatic lesions: do we need a different cutoff for recommending prophylactic fixation?

Authors:  Katie A Hoban; Samantha Downie; Douglas J A Adamson; James G MacLean; Paul Cool; Arpit C Jariwala
Journal:  JSES Int       Date:  2022-04-25

4.  [Surgical treatment of pathologic fractures of the humerus and femur].

Authors:  G Gruber; M Zacherl; A Leithner; C Giessauf; M Glehr; H Clar; R Windhager
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

5.  Minimally invasive treatment of pathological fractures of the humeral shaft.

Authors:  Onder Ofluoglu; Bulent Erol; Zerrin Ozgen; Muzaffer Yildiz
Journal:  Int Orthop       Date:  2008-04-03       Impact factor: 3.075

6.  Treatment of pathological humeral shaft fractures with intramedullary nailing. A retrospective study.

Authors:  Juan Pretell; Juan Rodriguez; David Blanco; Alberto Zafra; Carlos Resines
Journal:  Int Orthop       Date:  2009-07-02       Impact factor: 3.075

7.  Prophylactic stabilization for bone metastases, myeloma, or lymphoma: do we need to protect the entire bone?

Authors:  Hasham M Alvi; Timothy A Damron
Journal:  Clin Orthop Relat Res       Date:  2012-10-27       Impact factor: 4.176

8.  Use of Ligament Advanced Reinforcement System tube in stabilization of proximal humeral endoprostheses.

Authors:  Nikolaos A Stavropoulos; Hassan Sawan; Firas Dandachli; Robert E Turcotte
Journal:  World J Orthop       Date:  2016-04-18

9.  Intercalary prosthetic replacement is a reliable solution for metastatic humeral shaft fractures: retrospective, observational study of a single center series.

Authors:  Zhiqing Zhao; Zhipeng Ye; Taiqiang Yan; Xiaodong Tang; Wei Guo; Rongli Yang
Journal:  World J Surg Oncol       Date:  2021-05-05       Impact factor: 2.754

10.  Modular prostheses in the treatment of proximal humerus metastases: review of 40 cases.

Authors:  C Scotti; F Camnasio; G M Peretti; F Fontana; G Fraschini
Journal:  J Orthop Traumatol       Date:  2008-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.